Extension in AS: Sustainability of Benefits, Safety and Tolerability

NCT01863732 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

274

Enrollment

INDUSTRY

Sponsor class

Conditions

Spondylitis, Ankylosing

Interventions

BIOLOGICAL: Secukinumab
OTHER: Placebo (Pbo)

Sponsor

Novartis Pharmaceuticals